consumer-safety
6 stories related to this topic, newest first.
Utz Recalls Zapp's and Dirty Brand Potato Chips Nationwide Due to Salmonella Risk
Utz Quality Foods has initiated a voluntary recall of multiple varieties of Zapp's and Dirty brand potato chips sold nationwide. The recall stems from potential salmonella contamination in an ingredient, specifically dry milk powder in the seasoning. No illnesses have been report…
Japan's NITE Reports 310 Accidents with Secondhand Products Through 2024
The National Institute of Technology and Evaluation in Japan documented 310 accidents involving secondhand products over five years ending in 2024. Most incidents were fires, often related to lithium-ion batteries in items like bicycles and heaters. The institute advised consumer…
Senator Rand Paul Introduces Bipartisan Bill to Regulate Hemp Industry
Senator Rand Paul introduced legislation aimed at regulating the hemp industry to support commerce and consumer safety. The bill addresses restrictions from the 2026 agricultural appropriations bill and has bipartisan cosponsors. It seeks to prevent certain synthetic products whi…
Popular White Rice Brand Recalled Nationwide Over Possible Foreign Material
A popular brand of white rice sold in stores across the country is subject to a nationwide recall due to potential foreign material contamination. The recall affects products available in multiple locations. No further details on the brand or specific risks were provided in avail…
Over 350,000 Iron-Containing Supplements Recalled Due to Missing Child-Resistant Caps
The Consumer Product Safety Commission announced a recall of more than 350,000 units of vitamins and dietary supplements manufactured by Vitaquest International. The products lack child-resistant safety caps, violating the federal Poison Prevention Packaging Act. Consumers can ob…
NIH Image Gallery from Bethesda, Maryland, USA / Wikimedia (Public domain)Health Influencers Promote Unapproved Peptide Injections Amid FDA Oversight Concerns
Health and wellness influencers are promoting unapproved peptide injections through gray market channels. These treatments lack FDA approval and pose risks to consumer health. The trend raises questions about the agency's regulatory future.